TrialJournal of the European Academy of Dermatology and Venereology : JEADV2021

Oral gliadin-protected superoxide dismutase in addition to phototherapy for treating non-segmental vitiligo: A 24-week prospective randomized placebo-controlled study.

E Fontas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.